← Leaderboards
John L Goodier
University Of Pennsylvania
$1,298,761
Attributed
$1,298,761
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $245.6K · FY2014–19$250K$187.5K$125K$62.5K$0
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$1,298,761 · 4
By mechanism
R21$1,136,761 · 3
R03$162,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Kazuko Nishikura$15,062,070
- Robert H. Silverman$18,272,403
- Susan R. Weiss$24,407,392
- Boris Striepen$21,753,911
- Ghadeer K. Dawwas$930,886
Others in their field
Top investigators on “Transposon/Insertion Element”
- John M. Sedivy · Brown University$5,181,883
- Wade H Berrettini · University Of Pennsylvania$5,015,589
- Robert Scott Fulton · Washington University$4,074,183
- Ting Wang · Washington University$4,074,183
- Hui Shen · Van Andel Research Institute$3,996,845
- Haig H. Kazazian · Children'S Hospital Of Philadelphia$3,061,972
Research focus
Transposon/Insertion ElementFuturePseudogenesTissuesHuman DnaEndonucleaseMalignant NeoplasmsPaste SubstanceRetrotranspositionRna-Directed Dna PolymeraseInvestigationVariantRetrotransposonGenomeElementsBrainMutationCellsAmyotrophic Lateral SclerosisInsightInterestHuman GenomeBaseImmunocytochemistry
Grant awards (8)
Retrotransposition independent LINE 1-induced DNA damage in normal and aging cells$204,688
R21 · FY2019 · AG · contact PI
Retrotransposition independent LINE 1-induced DNA damage in normal and aging cells$245,625
R21 · FY2018 · AG · contact PI
A role for endogenous retroelements in Aicardi-Goutieres Syndrome$204,323
R21 · FY2017 · HD · contact PI
A role for endogenous retroelements in Aicardi-Goutieres Syndrome$244,375
R21 · FY2016 · HD · contact PI
Exploring a role for LINE1 retrotransposons in neurodegenerative disease$81,000
R03 · FY2015 · NS · contact PI
Exploring a role for LINE1 retrotransposons in neurodegenerative disease$81,000
R03 · FY2014 · NS · contact PI
Retrotransposons as site-specific gene delivery vectors$118,875
R21 · FY2003 · GM
Retrotransposons as site-specific gene delivery vectors$118,875
R21 · FY2002 · GM